SCHEMBL6180992

SCHEMBL6180992

N#CC1(c2ccc(CBr)cc2)CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
OPRM1 P35372 4/20 0.41
MAP4K4 O95819 1/20 0.40
LMNA P02545 2/20 0.39
TP53 P04637 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
OPRL1 P41146 2/20 0.38
IL4I1 Q96RQ9 1/20 0.37
WDR5 P61964 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL118612 0.91 OPRM1 (0.44) OPRM1OPRL1IL4I1
SCHEMBL27340577 0.86 OPRM1 (0.40) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL16897451 0.83 OPRM1 (0.39) OPRM1OPRL1IL4I1
SCHEMBL27729280 0.82 LOXL2 (0.42) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL6802583 0.80 OPRM1 (0.43) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL6209121 0.79 WDR5 (0.48) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL3954776 0.79 ALDH1A1 (0.40) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL1141221 0.77 WDR5 (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL27668282 0.76 OPRM1 (0.43) MEN1KMT2AOPRM1OPRL1IL4I1
SCHEMBL10227286 0.76 CYP2A6 (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0920424-B1 NON-PEPTIDE BOMBESIN RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 2005-11-30 EP disclosed
US-6194437-B1 ANTIDEPRESSANTS; ANTICANCER AGENTS; GASTROINTESTINAL DISORDERS; COGNITION ACTIVATORS WARNER-LAMBERT COMPANY 2001-02-27 US disclosed
EP-0485929-A1 Substituted azoles, process for their preparation and their application HOECHST AKTIENGESELLSCHAFT (DE) 1992-05-20 EP disclosed